Environment 15 September 2020 By Adam Vaughan Deforestation is harming biodiversityShutterstock / Richard Whitcombe The world hasn’t fully met any of the 20 biodiversity targets set by global governments a decade ago, leading conservationists to condemn nature protection efforts as a “massive failure”. A United Nations report today reveals only six of the “Aichi targets”…
(File, Screengrab via AFP) Warmer temperatures have caused a 113-square-kilometre block of ice to break off from the Arctics's largest ice shelf.It is normal for pieces of ice to break off from a glacier but is is usually not this huge.A recent study predicts that Greenland's melting ice could raise sea levels by 10 to…
Deputy President David Mabuza. (Jan Gerber/News24) Deputy President David Mabuza has commended Public Works and Infrastructure Minister Patricia de Lille's efforts to root out corruption in her department.Mabuza said the government has taken several measures to ensure money meant for infrastructure projects are spent correctly.He was answering questions in the National Council of Provinces on…
A study intended to track the coronavirus in Oregon and understand its impacts on minorities is now dead because Oregon Health & Science University, which led the research, failed to ensure enough minorities would sign up to participate.The Key to Oregon study, which had been projected to cost $24 million over a year, was to…
RG Snyman (Photo By Ramsey Cardy/Sportsfile via Getty Images) World Cup winner RG Snyman has been ruled out for at least six months with a knee injury.Snyman was injured in Saturday's PRO14 clash between his new club Munster and Leinster.The injury rules Snyman out of this year's Rugby Championship.The Springboks have been dealt a massive…
The FDA has cleared the interleukin (IL)-23 inhibitor tildrakizumab (Ilumya) for the treatment of active psoriatic arthritis (PsA) in adults. Sun Pharma announced the approval on October 30. “As an IL-23 inhibitor administered exclusively by a healthcare provider, Ilumya is now an option for adults with active psoriatic arthritis who are unable to self-administer treatment
Millions of Medicare enrollees who buy stand-alone prescription drug plans will see their average monthly premiums rise by 50% in 2027, a new analysis finds. But enrollees can avoid the average increase — from $34 a month to $51 — by switching to lower-cost plans during the program’s open enrollment period, which runs through Dec.
You don't have permission to access "http://www.medpagetoday.com/washington-watch/washington-watch/123652" on this server. Reference #18.d494d817.1793332899.22e6a54f https://errors.edgesuite.net/18.d494d817.1793332899.22e6a54f